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Protein aggregation is the underlying cause of many diseases, and also limits the usefulness of 
many natural and engineered proteins in biotechnology. Better mechanistic understanding and 
characterization of aggregation-prone states, is needed to guide protein engineering, 
formulation, and drug-targeting strategies that prevent aggregation. While several final 
aggregated states - notably amyloids – have been characterized structurally, very little is known 
about the native structural conformers that initiate aggregation. We used a novel combination of 
small-angle X-ray scattering (SAXS), atomistic molecular dynamics (MD) simulations, single-
molecule FRET (smFRET), and aggregation-prone region (APR) predictions, to characterize 
structural changes in a native humanized Fab A33 antibody fragment, that correlated with the 
experimental aggregation kinetics.  SAXS revealed increases in the native state radius of 
gyration, Rg, of 2.2% to 4.1%, at pH 5.5 and below, concomitant with accelerated aggregation. 
In a cutting-edge approach, we fitted the SAXS data to full molecular dynamics simulations from 
the same conditions, and located the conformational changes in the native state to the constant 
domain of the light chain (CL). This CL displacement was independently confirmed using 
smFRET measurements with two dual-labelled Fabs. These conformational changes were also 
found to increase the solvent exposure of a predicted aggregation-prone region (APR), 
suggesting a likely mechanism through which they promote aggregation. Our findings provide a 
means by which aggregation-prone conformational states can be readily determined 
experimentally, and thus potentially used to guide protein engineering, or ligand binding 
strategies, with the aim of stabilizing the protein against aggregation. 
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Elucidating how proteins misfold or partially unfold before they aggregate remains a key 
challenge with significant impact in medicine and biotechnology [1]. In the last 30 years, 
antibody-based products have become the main drug class for new approvals in the 
pharmaceutical industry [2], used to treat human diseases, mainly in oncology, autoimmunity 
and chronic inflammation [3].  However, many natural or newly engineered proteins suffer from 
aggregation during development, which is highly undesirable as they may elicit adverse immune 
responses in patients, and so must be avoided [4,5].  
Protein stability is only marginal, and stresses to the system (such as changes in pH, 
salt concentration or temperature), can perturb the native structure of the protein and trigger 
aggregation [6]. Aggregates are also observed at all stages of drug product development, 
including expression, purification, shipping and storage [7,8]. Protein engineering and 
formulation are two potential avenues to minimize protein aggregation. However, in order to 
improve success, the molecular mechanisms that lead to aggregation need to be understood 
first, so that informed rational decisions can be made. Thus, understanding the mechanisms by 
which soluble protein molecules misfold and aggregate is of fundamental and biomedical 
importance.  
The most widely accepted aggregation mechanism involves two steps: (i) a 
conformational change to the protein native state and (ii) the assembly of protein molecules into 
aggregates [9]. Initially, the native state experiences a conformational change to form an 
aggregation-prone state. This intermediate or native-like state is believed to expose 
aggregation-prone regions, which are normally shielded in the native protein [10]. Then, 
assembly into aggregates is driven by the hydrophobic effect, or the propensity of exposed 
sequences to form cross- sheets [11]. The first step is controlled by the conformational stability 















by the free energy of unfolding Gunf of the native protein relative to the fully unfolded state. The 
second step, the assembly into aggregates, is controlled by the persistence time, or relative 
population of aggregation-prone states, their ability to form specific intermolecular interactions, 
and their colloidal stability in terms of intermolecular attractive and repulsive forces. Many 
proteins aggregate with first-order kinetics, implying a unimolecular rate-limiting step linked to 
conformational changes or partial unfolding, rather than a rate-limiting bimolecular association 
of two protein molecules [9]. It is therefore important to characterize the nature of any 
conformational changes in the native state that can promote aggregation. 
For many years, experiments have tried to characterize the states that precede 
aggregation [12]. Initial studies suggested that aggregation takes place from the fully-unfolded 
state of the protein, drawn from early observations of proteins at elevated temperatures. 
However, increasing evidence suggests that, at storage temperatures below the melting 
temperature (Tm) of the protein, aggregation takes place from near-native states, where only 
partial or transient local-unfolding of the protein occurs [13]. This hypothesis is supported by 
recent work on Fab A33, where it was found that the melting temperatures of the protein under 
different conditions were only correlated with aggregation kinetics that were determined at 
temperatures elevated to just below the Tm of the protein, where aggregation from the unfolded 
state therefore predominated [14].  By contrast, Tm did not correlate with the aggregation 
kinetics determined at lower storage temperatures, indicating that global unfolding was no 
longer the cause of aggregation.  
Many studies have reported the presence of near-native states of proteins that are 
aggregation-prone. For example, a combined analysis of kinetics and solution thermodynamics 
of recombinant human interferon-, found that only a 9% expansion of the native-state surface 
area was necessary to form the intermediate state that preceded aggregation [15]. Similar 















intermediate state preceding aggregation represented only 15% of the change in surface area 
observed for the completely unfolded conformation [16]. More recently, only transient local 
unfolding was found necessary to show faster aggregation for variants of human lysozyme, 
using hydrogen/deuterium exchange experiments [17]. Studies on hyperthermophilic 
acylphosphatase, superoxide dismutase 1, transthyretin, 2-microglobulin and Fyn SH3 also 
showed that global unfolding was not necessary, and that aggregation could be initiated from 
locally unfolded states [18,19]. NMR was able to resolve a structural folding intermediate of the 
6.4kDa Fyn SH3 domain that was more aggregation-prone than the native state [19]. However, 
this relied upon mutations that stabilized the folding intermediate, and so the use of NMR to 
characterize directly pre-aggregational states in unmutated native-ensembles remains very 
challenging, particularly for larger proteins such as the 48 kDa humanized antibody fragment 
Fab A33.  
As an alternative new approach, we combined small angle X-ray scattering (SAXS) with 
molecular dynamics (MD) simulations, and verified the results using single-molecule Förster 
Resonance Energy Transfer (smFRET), to characterize a pH-dependent shift in the native 
ensemble conformation of the humanized antibody fragment Fab A33 (Fig. 1; Fig. S1). Such 
antibody fragments bring therapeutic advantages, including deeper tissue penetration [20], and 
are also simpler and less costly to manufacture in prokaryotes, by removing the Fc domain and 
the accompanying need for glycosylation [21].  The conformational shift was correlated with the 
accelerated aggregation kinetics measured under the same native conditions. SAXS showed 
that Fab A33 adopted an expanded conformation at pH below 7.0, with a 2.2-4.1% increase in 
the radius of gyration. This expanded conformation was more aggregation-prone, and small 
amounts of aggregates were also detected by SAXS. To understand the molecular structure of 
this expanded conformation, the SAXS data were combined with structures generated using MD 
simulations. We found that the constant domain of the light chain (CL) became more open and 















which donor and acceptor fluorophores were attached at specific locations in Fab A33, and the 
distance between them was monitored. Our results support increasing evidence that 
aggregation at temperatures well below the Tm of the protein takes place from near-native 
states, and does not require global unfolding. The conformational states preceding aggregation 
are very similar to the native structure at pH 7.0, but they are more expanded due to local 




Small-angle scattering identified an expanded aggregation-prone conformation 
SAXS is a diffraction technique that characterizes the structure of a protein in solution 
[22]. By studying the protein in different solution conditions, it is possible to elucidate changes in 
conformation. Here, we investigated the effect of pH and salt concentration upon the Fab A33 
structure (Fig. 2). X-ray scattering curves were acquired for Fab A33 at 1 mg/ml in 20 different 
conditions that combined five pH values (3.5, 4.5, 5,5. 7.0 and 9.0) and four ionic strengths (IS) 
(20, 50, 150 and 250 mM). These yielded the radius of gyration Rg and the intensity at zero Q 
I(0), the latter being proportional to the molecular weight. The Rg and I(0) values were obtained 
using both Guinier analyses of the low Q region, and pair density distribution P(r) analyses from 
the full scattering curve. Both analyses gave consistent results (Fig. 2; Fig. S2). The Guinier 
plots revealed trace amounts of aggregates at low Q, especially for the samples below pH 7.0 
(red; Fig. 2a). The aggregates were seen when the I(Q) intensities curved upward. When the 
intensities were fitted to larger Q values, linear non-aggregated Guinier plots with satisfactory 
Q.Rg ranges were identified that were distinct from the Guinier fits for aggregated Fab A33. This 
analysis was confirmed from the I(0)/c values from the fits at larger Q (Fig. 2b), where these 
were seen to be similar at around 40 (39 ± 3) for almost all 20 solution conditions. This outcome 















aggregation. Thus, for all samples, two Q ranges were fitted, namely the larger Q range of 0.37-
0.5 nm-1 that monitored the structure of the monomer, and the shorter Q range of 0.14-0.3 nm-1 
to monitor the degree of sample aggregation. As previously used [23], aggregation levels were 
monitored using I(0)/c [= (I(0)Q: 0.14-0.3 nm 
-1
 – I(0)Q: 0.37-0.5 nm 
-1)/c], which used the monomeric I(0) 
values as baseline to monitor the aggregation that had taken place (Fig. 2d).  
 At acidic pH (5.5, 4.5 and 3.5), SAXS detected the presence of a more expanded or 
partially unfolded conformation of Fab A33 when compared to neutral pH (7.0 and 9.0) (Fig. 2c). 
The Rg values increased from 2.62 nm at pH 7.0 and 2.64 nm at pH 9.0 to 2.70 nm at pH 3.5, 
2.73 nm at pH 4.5, and 2.71 nm at pH 5.5 (mean ± SEM of 0.01 nm). These correspond to Rg 
increases of between 2.2% and 4.1% from neutral pH (7.0 and 9.0) to acidic pH (5.5, 4.5 and 
3.5). We also observed that pH had a bigger effect on the conformation of Fab A33 than salt, 
whereby an increase in the IS of the solution from 20 to 250 mM had little effect on Rg (e.g., Rg 
increased at pH 7.0 from 2.60 nm to 2.64 nm, and at pH 4.5 from 2.72 nm to 2.73 nm (mean ± 
SEM of 0.01 nm)). These results are consistent with previous reports that showed that pH had a 
bigger influence on protein conformations [24]. 
 Protein aggregation was monitored using I(0)/c. Small amounts of aggregates in the 
samples at acidic pH (5.5, 4.5 and 3.5) were detected, in contrast to the samples at neutral pH 
(7.0 and 9.0) where no aggregates were found (Fig. 2d). Thus, the same conditions that 
resulted in an expanded conformation of Fab A33 led to its accelerated aggregation, to indicate 
that the expanded conformation of Fab A33 is aggregation-prone. Interestingly, no aggregates 
were detected in the pH 3.5 samples at a low IS of 20 mM, unlike for the pH 4.5 and 5.5 
samples. This is probably due to colloidal stabilization at pH 3.5 and low IS, where Fab A33 is 
highly protonated, and so repulsive forces between positively charged proteins prevents their 
aggregation. When salt concentration is increased (Fig. 2d, pH 3.5 and IS of 50, 150 and 250 















aggregation. These results are consistent with the Fab A33 aggregation kinetics observed 
previously [14] for which the pH 3.5 samples at low IS also aggregated much more slowly than 
at higher pH or IS. Our findings also suggest that the addition of salt mainly contributes to 
charge shielding, and does not destabilize the native conformation sufficiently to induce global 
unfolding. 
 The Rg results were correlated with our previously-reported aggregation rates (v) [14], 
obtained by monitoring monomer loss by SEC-HPLC in the same 20 experimental conditions at 
23 C.  The initial rates of monomer loss as a function of pH and ionic strength were increased 
to 0.027 ± 0.003 % day−1 at pH 3.5-5.5, compared to rates of 0.009 ± 0.0018 % day−1 at pH 7-9 
(Fig. S3). Thus, the experimental conditions that caused an increase in Rg (pH 3.5, 4.5, and 5.5) 
also resulted in faster aggregation rates than at neutral pH (7.0 and 9.0) (Fig. 3). These results 
confirm that the expanded conformation of Fab is more aggregation-prone. 
 
MD simulations captured pH-induced unfolding and identified flexible regions 
A homology model of Fab A33 was generated using Rosetta, given that no crystal 
structure of Fab A33 was available. PropKa software was used with this model to determine the 
protonation state of the ionizable residues [25]. This gave the following total charges: +35 (pH 
3.5), +18 (pH 4.5), +12 (pH 5.5), +9 (pH 7.0) and +5 (pH 9.0). This structure was used as the 
starting point for MD simulations using Gromacs [26–28]. These were carried out for 50 ns at pH 
3.5, 4.5, 5.5, 7.0 and 9.0 for an IS of 50 mM. Simulations were performed at three different 
temperatures: 300 K, 340 K and 380 K. For each of the 15 conditions, three independent 
simulations were performed. 
The MD simulations at 300 K were used to calculate the Rg value of Fab A33 and its 
solvent accessible surface area (SASA) as a function of simulation time for each pH (Figs. 4a 
and 4b). For each pH, the three simulation repeats were averaged at each time point (10 ps) to 















simulations were able to capture the increase in Rg and SASA as the pH decreased, in 
agreement with the SAXS results (Fig. 2c). Note that the Rg values from the simulations were 
smaller than those obtained from SAXS because no account was taken of the hydration shell 
visible by SAXS, nonetheless the trends were clear. The MD simulations at pH 7.0 and 9.0 gave 
an Rg of 2.52 nm and 2.51 nm (mean ± SEM of 0.01 nm), respectively, whereas at pH 3.5 this 
increased to 2.58 nm ± 0.02 nm. At pH 4.5 and 5.5, the Rg increases were not yet as large as 
those measured experimentally with SAXS.  MD simulations do not update the protonation state 
of molecules continuously as the protein structure unfolds, and this would limit the rate of 
structural change during simulation, most critically at pH 4.5-5.5, which overlaps the pKa range 
of acidic residues. In accord with the Rg changes, the SASA increased from 210 nm
2 at pH 7.0 
and 9.0, to 220 nm2 at pH 3.5. 
The MD simulations also provided information about protein dynamics potentially down 
to the level of individual residues. The flexible regions of Fab A33 were assessed using the root 
mean square fluctuation (RMSF), this being the average distance that a residue moves during 
the simulation. The RMSF for the last 30 ns of each simulation (20-50 ns) were averaged for 
each residue, and visualized by color in Fig. 4c and 4d for pH 7.0 and pH 3.5 respectively. Less 
flexible residues are shown in blue and more flexible residues in red. For pH 7.0, the most 
flexible regions were found to be the loop regions, followed by the α-helical regions, then the -
strand regions. The highest flexibility was seen in the CDR loops, the C-terminus of the heavy 
chain, and several loops and α-helices. The -strands of the CL and CH1 domains were more 
flexible than the VL and VH domains. For pH 3.5, Fab A33 was seen to be more flexible than at 
pH 7.0. In addition to the regions seen to be flexible at pH 7.0, which were also flexible at pH 
3.5, both the CL and CH1 domains showed increased flexibility at low pH. Together with the Rg 















expanded conformation and specific regions with increased flexibility. These are characteristics 
expected of aggregation-prone conformers. 
 
Atomistic modelling of SAXS data to characterize the expanded conformation 
The atomistic modelling of full SAXS curve to large Q values enables additional 
information about the structure of Fab A33 to be obtained beyond the low resolution Rg 
analyses. Theoretical X-ray scattering curves can be calculated from each atomistic model for 
comparison to the experimental SAXS curves to identify best fit structures that are 
representative of the average solution structure of Fab A33. This has been applied to a range of 
protein structures [29–31]. 
Each MD simulation above recorded 5,000 structural snapshots of the 50 ns simulations 
at every 10 ps, i.e. 45,000 structural models for each pH value. A theoretical scattering curve 
was calculated for each model for comparison against its corresponding experimental SAXS 
curve at the same pH and NaCl concentration. The R-factor goodness-of-fits were calculated by 
comparing the theoretical and experimental curves in the Q range of 0.37-1.6 nm-1. Each 
theoretical Rg value was also calculated from the theoretical scattering curves from Guinier 
analysis in the same Q range (0.37-0.5 nm-1) as that used above. The sets of R-factor vs. Rg 
plots for each pH show the extent to which the 45,000 models converge with the experimental 
data. All five plots showed minima of less than 2% at theoretical Rg values close to the 
experimental Rg values (vertical lines; Fig. 5a), indicating very good fits had been obtained. The 
presence of these minima indicated that enough Fab A33 conformations had been sampled, 
although simulations at higher temperatures were required at pH 4.5 and 5.5 to verify that 
minima had been reached in these cases. This outcome reflected the observation above that 
the simulations at pH 5.5 and 300 K did not fully capture the conformational change seen by 
SAXS. The ten best fit models for each pH are highlighted in yellow, all being within one 















different Rg values for each pH, implying that the above conformational differences had been 
followed in the fits. The best-fit modelled SAXS and experimental I(Q) curves were overlaid, and 
likewise the experimental and best-fit modelled P(r) curves were overlaid (Fig. 5b). Visual 
inspection showed very good fits. The best-fit structures showed that Fab A33 had a more 
compact structure at pH 7.0 and 9.0, and was partially unfolded to a more expanded 
conformation at pH 5.5, 4.5 and 3.5.  
Alignments of the sets of ten best-fit structures were performed to gain insights into the 
expanded conformation of Fab A33 at low pH. The best-fit structures from pH 7.0 were first 
considered (Fig. 6). These structures did not align perfectly, indicating that Fab A33 is flexible at 
pH 7.0. The RMSD of each Fab domain was calculated relative to the structure that best fitted 
the SAXS experimental data at pH 7.0, as reference. As expected from their antigen-binding 
role, the CDR loops showed high flexibility, with a median RMSD of 0.18 nm and an interquartile 
range of 0.13-0.21 nm. Interestingly, the CH1 domain also showed high flexibility with an RMSD 
of 0.17 nm and range of 0.10-0.19 nm. In particular, the CH1 C-terminal β-strand connected to 
the hinge peptide showed wide conformational variability. In the full-length antibody, the hinge is 
attached to the Fc region, which may provide additional stability. The VH and CL domains 
showed RMSDs and ranges of 0.15 nm (0.14-0.16 nm) and 0.10 nm (0.09-0.12 nm) 
respectively. The VL domain showed the least variability with a RMSD and range of 0.08 nm 
(0.08-0.09 nm) and good alignment of all the -strands. 
Next, the alignment of the ten best-fit structures at pH 7.0 to those at pH 3.5 provided 
structural information about the pH-induced conformational change of Fab A33 (Fig. 7). The 
RMSDs at pH 3.5 were also calculated relative to the reference best fit structure at pH 7.0. 
Notably, the CL domain was the only domain to show a significant increase in RMSD as the pH 
was decreased. The RMSD and range of the CL domain increased to 0.16 nm (0.13-0.17 nm) at 















displacement of this domain at low pH (magenta; Fig. 7a), being more open to solvent at pH 3.5. 
This pH-dependent domain displacement was clearly visualized in two loops (light chain 
residues 150-159 and 198-205; arrowed in Fig. 7a) which connect CL -strands. The α-helix at 
residues 183-188 of the CL domain was displaced. The -sheet structure was lost in 8 out of 10 
of the CL best structures at pH 3.5 in residues 144-147, which suggests an increased flexibility 
in this segment. Additional views of the best-fit structures at pH 7.0, 5.5 and 3.5 in Fig. S4 
provide further visual support for the conformational shift at low pH in the CL domain. 
No corresponding systematic displacements were found at pH 3.5 for the other three 
domains, even though these showed comparable RMSDs and ranges of 0.10 nm (0.09-0.10 
nm) for the VL domain, 0.17 nm (0.16-0.17 nm) for the VH domain and 0.18 nm (0.16-0.20 nm) 
for the CH1 domain, each relative to the best fit Fab A33 structure at pH 7.0. As seen at pH 7.0, 
the CH1 domain was relatively flexible in sampling a wide range of conformations, particularly in 
the C-terminal -strand connected to the C-terminal hinge (Fig. 7b). The hinge itself was highly 
extended at pH 3.5, and adopted a range of conformations. The five sets of ten best-fit MD 
structures at each pH value are downloadable in Supplementary Data Online. 
In order to obtain a better picture of the displacements experienced by the whole Fab 
A33 molecule at low pH, distances between the four domains were also measured, using one 
cysteine in each domain. Six distances were monitored in total (VL-VH, CL-CH1, VL- CL, VH- CH1, 
VL-CH1 and VH- CL), using the four cysteines located in outer ß-strands (C23, C194, C236, 
C414), (Fig. S5). The six distances were calculated for the ten best SAXS fit structures at pH 
7.0 and the ten best SAXS fit structures at pH 3.5, and their averages and SEM are reported 
(Table 1). Results confirmed that the displacement at low pH occurred in the CL domain, given 
that the only inter-domain distances that increased between pH 7.0 and 3.5, were the distances 















of VL-CL (0.29 ± 0.07 nm), VH-CL (0.27 ± 0.03 nm) and CL-CH1 (0.05 ± 0.02 nm). By contrast, the 
distances between the other domains did not change significantly.  
 
Table 1. Inter-domain distance differences between the best SAXS fit structures at pH 7.0 
and 3.5, using one cysteine in each domain (VL, VH, CL and CH1). Six distances were 
monitored between the four Fab domains (VL-VH, CL-CH1, VL- CL, VH- CH1, VL-CH1 and VH- CL) 
using the four cysteines (C23, C194, C236, C414) located in the outer ß-strands. These are 




pH 7.0 pH 3.5 ∆pH (3.5 - 7.0) 




C23 (VL) - C236 (VH) 3.00 0.02 2.95 0.01 -0.05 0.03 
C194 (CL) - C414 (CH1) 2.47 0.02 2.52 0.01 0.05 0.02 
C23 (VL) - C194 (CL) 4.18 0.02 4.47 0.06 0.29 0.07 
C236 (VH) - C414 (CH1) 4.11 0.07 4.09 0.06 -0.02 0.09 
C23 (VL) - C414 (CH1) 4.68 0.06 4.64 0.02 -0.05 0.06 
C236 (VH) - C194 (CL) 4.99 0.02 5.26 0.02 0.27 0.03 
 
 
smFRET to confirm the CL domain displacement at low pH 
To confirm the MD and SAXS modelling of displacements within the CL domain at low 
pH, we used smFRET. FRET is the radiation-less transfer of energy from a donor fluorophore to 
an acceptor in a range of 2-10 nm distances [32–35]. smFRET is thus sensitive to such distance 
changes, and can study conformational changes in proteins [36–39]. Here, the apparent FRET 















that have been transferred to the acceptor was used to report the separation between the donor 
and acceptor. 
Two donor-acceptor constructs were generated to probe an intra-CL separation and a 
separation between the CL domain and the heavy-chain linker (Fig. 8a). Specifically, these were 
(Dist 1) LC-K126pAzF + LC-S156C, and (Dist 2) HC-S117pAzF + LC-S156C. Each construct 
contained one unnatural amino acid [42], p-azido-l-phenylalanine (pAzF), and one solvent-
exposed cysteine [43,44] to attach the fluorophores Alexa Fluor 488 (donor) and Alexa Fluor 
594 (acceptor). The labelling was confirmed using ESI mass spectrometry and UV-vis 
absorption spectra (Figs. S6 and S7). The confocal detection of freely diffusing molecules was 
used to obtain the apparent transfer efficiency histograms (Eapp) of Fab A33 at pH 7.0 and 3.5 in 
an ionic strength of 50 mM (Fig. 8a). The peaks at a FRET efficiency of zero correspond to 
molecules with no active acceptor fluorophore, and these peak backgrounds are in grey. The 
peaks at high FRET efficiencies correspond to Fab A33 molecules with one donor and one 
acceptor. To determine their mean transfer efficiencies, these were fitted to Gaussian peak 
functions (black lines). Raw data were shown in the form of distributions of inter-photon delays 
(Fig. S8), together with controls of Fab A33 unfolding using guanidinium chloride (GdmCl) (Figs. 
S9 and S10). 
smFRET showed that the intra-CL distance (Dist 1) did not change with pH, as the same 
FRET efficiency value (Eapp = 0.97) was found at pH 7.0 and pH 3.5 (Fig. 8a). In contrast, the 
distance between CL and the heavy chain linker (Dist 2) increased at pH 3.5, with a decrease in 
FRET efficiency from Eapp = 0.87 at pH 7.0 to Eapp = 0.78 at pH 3.5 (Fig. 8a). These results 
indicated the displacement of the CL domain and the partial unfolding of Fab A33 at low pH. On 
comparing this outcome to the atomistic modelling of the SAXS data, the ten best fit structures 
at pH 7.0 and pH 3.5 were examined (Fig. 8b). Dist 1 was unchanged with pH, being 2.5 ± 0.1 
nm at pH 7.0 and pH 3.5. However, Dist 2 increased from 2.8 ± 0.4 nm at pH 7.0 to 3.5 ± 0.1 nm 















Dist 1 and Dist 2 were also monitored during the MD simulations at pH 7.0 and 3.5 (Fig. 8c). 
Dist 1 was unchanged during the simulation, while Dist 2 increased from 2.9 ± 0.3 nm at pH 7.0 
to 3.3 ± 0.2 nm at pH 3.5. Both the atomistic SAXS modelling and the MD simulations confirmed 
the experimentally observed displacement at low pH of the CL domain by smFRET.  
 
Identification of Aggregation-Prone Regions (APR) suggests aggregation mechanism 
Computational biology tools were used to predict the regions in proteins most likely to 
form and stabilize the cross- structure characteristic of aggregates. These aggregation-prone 
regions (APRs) are mostly hydrophobic, possess a low net charge, and have a high propensity 
to form -sheets. Several methods have been developed to predict the presence of APRs in a 
protein. The first methods only used the protein sequence as input, this being equivalent to the 
fully unfolded state. Predictions were based on either the intrinsic properties of amino acids, or 
their compatibility with protein structural features in known amyloid fibril structures [10].  
Examples include TANGO [45], AGGRESCAN [46], PASTA [47], MetAmyl [48], FoldAmyloid 
[49], FishAmyloid [50] and Waltz [51]. As these predictions do not always agree, Amylpred2 
generates a consensus from up to eleven existing algorithms [52]. However, it is known that 
APRs are frequently buried inside the hydrophobic core of globular proteins, and so their ability 
to trigger aggregation would depend upon solvent accessibility, i.e. the potential of the APR to 
become solvent exposed through structural dynamics or partial unfolding. Thus, more recent 
methods include aspects of the protein structure to predict APRs, including AGGRESCAN 3D 
[53], AggScore [54], SAP [55] and Solubis [56]. 
Here, we have already identified the solution conformations of Fab A33 in different 
solution conditions via SAXS atomistic modelling. Thus, we determined APRs using only 
sequence-based predictors, and combined them with the best experimentally identified 















based APR predictors were used in total, PASTA 2.0, TANGO, AGGRESCAN and MetAmyl, to 
predict the APRs in Fab A33. APRs, where three out of the four predictors identified an 
aggregation-prone sequence and were selected (Fig. S11a). Seven segments showed the 
highest aggregation propensity values, namely residues 31-36, 47-51, 114-118 and 129-139 in 
the light chain and residues 261-165, 325-329 and 387-402 in the heavy chain.  Additionally, 
these APRs were confirmed using Amylpred2, which identified the same APRs in addition to 
others (Fig. S11a).  
To display the aggregation-prone regions on the Fab A33 homology model as shown in 
Fig. 9a, each aggregation propensity was normalized between 0 and 1, and weighted equally 
(Fig. S11b). Red represented high aggregation propensities and blue low aggregation 
propensities. The seven APRs were co-located as three regions of largely buried -strands 
within the folded structure, and all were protected from the solvent. Next, the difference in 
solvent accessibility of the APRs in the SAXS best-fit structures at pH 7.0 and pH 3.5 were 
analysed. The solvent accessibility of one APR visibly increased at pH 3.5 due to the 
displacement of the CL domain (circled; Figs. 9b and 9c). Quantitatively, the SASA of the seven 
APRs were calculated for the ten best-fit structures at pH 7.0 and pH 3.5, and summed (Table 
S1). While most APR showed small decreases in solvent accessibility, the APR at residues 387-
402 increased by 83 Å2 from 536 ± 43 Å2 at pH 7.0 to 619 ± 39 Å2 at pH 3.5 (3% increase), due 
to the displacement of the CL domain at low pH. These data illustrate the potential of combining 
biophysical methods that determine conformational changes, with sequence-based APR 
prediction tools, for determining aggregation hotspots. For Fab A33, the aggregation prediction 
tools suggested a possible molecular explanation for the observed increase in aggregation at 

















In order to prevent protein aggregation, the aggregation-prone conformations that lead to 
aggregation need to be elucidated first, so that rational strategies can be taken to prevent it. 
However, such aggregation-prone conformations for near-native solution conditions have 
proven most challenging to characterize over the years, and have remained elusive within 
unmutated native-protein ensembles. In this study, we combined orthogonal methods (SAXS, 
MD simulations, SAXS atomistic modelling, smFRET and APR predictions) to characterize the 
structural perturbations that take place within the native ensemble of the humanized antibody 
Fab A33 over a range of different pH and ionic strengths.  Formation of an expanded 
conformation of Fab A33 correlated with its increased aggregation propensity under native 
conditions. The conformational change was localized on the CL domain of the Fab, revealing 
that aggregation at near-native conditions proceeds through a state that is only slightly 
perturbed in structure relative to the native state. In the case of Fab A33, the radius of gyration 
increased between 2.2% and 4.1% for the aggregation-competent species relative to the native 
state. 
To explain the increased aggregation propensity of the expanded conformations of Fab 
A33, we used online tools to predict the aggregation-prone regions (APR) that are more likely to 
form cross- structures found in aggregates. All the APRs predicted for Fab A33 were buried in 
the protein interior and shielded from solvent. However, the displacement of the CL domain at 
low pH increased the solvent accessibility of one APR, presenting a likely route to aggregation. 
Future work to confirm this proposed aggregation mechanism, could include mutagenesis of the 
ionizable residues inferred to drive the pH-induced change, or to reduce the aggregation 
propensity of the exposed APR. Our findings are in accordance with an aggregation mechanism 
that proceeds through partially unfolded and transiently-populated conformations within the 
native ensemble [18,57]. The initial oligomers formed would thus retain high structure similarity 















re-arrangement takes place to form the typical cross- structure of amyloids, as indicated in 
previous studies [16,58,59]. 
Collectively, this work provides compelling evidence of how local unfolding can lead to 
transiently-formed structural conformers within the native ensemble that promote aggregation. It 
also highlights the promise of SAXS combined with molecular dynamics simulations to resolve 
aggregation-prone conformers within native ensembles, particularly for large proteins that are 
less accessible by NMR. This also provides a new route to gaining molecular level knowledge of 
potential target sites for the rational engineering of more stable proteins, either via protein 
engineering or formulation, or for the design of drugs that bind to and stabilize proteins against 




Materials and Methods 
 
Cloning, site-directed mutagenesis, expression and purification of Fab A33 
Wild-Type C226S Fab A33  
The gene coding for Fab A33 (Fig. S1) was kindly provided by UCB (Slough, UK) in the 
plasmid pTTOD in E. coli W3110, and the C226S heavy-chain variant was used to avoid the 
formation of linked Fab dimers. This variant was termed the wild-type Fab A33, which was 
expressed and purified as described previously [14].  
 
Fab A33 mutants for smFRET 
Fab A33 mutants with one non-natural amino acid, p-azido-l-phenylalanine (pAzF), and 















acceptor fluorophores. Two different constructs were generated: (i) LC-K126pAzF + LC-S156C 
and (ii) HC-S117pAzF + LC-S156C. To incorporate pAzF, the plasmid encoding for Fab A33 
was co-transformed into E. coli, with plasmid pEVOL-pAzF (Plasmid ID: 31186) (Addgene, 
Cambridge, USA), which encodes an engineered tyrosyl-tRNA synthetase/amber suppressor 
tRNA derived from Methanococcus jannaschii, to incorporate pAzF at the amber stop codon 
[60,61]. As pTTOD and pEVOL-pAzF had the same origin of replication p15A, the tac promoter 
and Fab A33 gene from pTTOD was sub-cloned into pET-29a(+) which has a ColE1 origin of 
replication using circular polymerase extension cloning (CPEC) [62]. CPEC primers (Eurofins, 




(Vector.FOR) CAGCTTCCGATGGTATCGCCGACATCACCGATGGG.  
The insert and vector were amplified by PCR using the CPEC primers, purified using QiaQuick 
gel purification kit (Qiagen, Hilden, Germany), assembled using a 30:1 (insert:vector) ratio with 
100 ng of vector and 10 cycles, then directly transformed into NEB 10 competent cells (New 
England Biolabs, Ipswich, US). Final assembly was confirmed by sequencing (pET29Fab_for: 
AGGAATGGTGCATGCAAGG, pET29Fab_mid: AGTGGAAGGTGGATAACGC, T7 term: 
CTAGTTATTGCTCAGCGG), using Source Bioscience (UK). 
Site-specific mutations were introduced using QuickChange Lightning Site-Directed 
Mutagenesis (Agilent Technologies, Santa Clara, USA) to form the double mutants: (i) LC-
K126pAzF + LC-S156C and (ii) HC-S117pAzF + LC-S156C. In order to incorporate pAzF, we 
mutated the native codon to the amber stop codon (TAG). The pEVOL-pAzF and variant pET-
29a plasmids were co-transformed into the engineered "amberless" E. coli (C321.A.exp) (ID: 















Expression was equivalent to wild-type Fab A33, with the addition of 1 mM pAzF (Chem-Impex 
International, Wood Dale, US), 34 µg/ml chloramphenicol, 50 µg/ml kanamycin, 0.2% L-(+)-
arabinose (as an inducer for pEVOL-pAzF), 0.2 mM IPTG (as an inducer for variant pET-29a 
containing Fab A33) and 2.5 µg/ml D-biotin (because the C321. A.exp strain is auxotrophic for 
D-biotin) (all final concentrations). 
 
Site-Specific Labeling of Fab A33 
Fab A33 was buffer-exchanged into PBS using 10 kDa cut-off centrifugal filters (Merck, 
Kenilworth, UK) and adjusted to 0.5 mg/ml. The donor fluorophore dibenzocyclooctyne Alexa 
Fluor 488 (Thermo Fisher Scientific, Waltham, USA) was reacted using click chemistry at a 5:1 
molar ratio (fluorophore:protein) for 24 h at room temperature with gentle shaking in the dark. To 
attach the acceptor to the Fab solvent-exposed cysteine using maleimide-thiol chemistry, TCEP 
was added to 0.5 mM (50-fold molar excess of TCEP to Fab), incubated for 1.5 h at room 
temperature [64], then removed by buffer exchange into PBS. Incubation for 24 h allowed 
reconstitution of the correct disulfide-bridges. Maleimide-activated Alexa Fluor 594 was added in 
a 5:1 molar ratio of fluorophore:protein, and incubated for 16-18 h at room temperature. 10 kDa 
centrifugal filters were used to remove the unreacted dye. The correct labelling of constructs i 
and ii was confirmed using ESI mass spectrometry and UV-vis absorption (Fig. S7). 
 
X-ray scattering data for Fab A33  
Small-angle X-ray scattering measurements were carried out on beamline BM29 at the 
European Synchrotron Radiation Facility (ESRF), Grenoble, France. Scattering data I(Q) were 
collected using a 2D Pilatus detector located 2.867 m from the sample, yielding a Q-range of 
0.025-5 nm-1, where Q = 4π sin θ /; 2θ is the scattering angle and  is the wavelength (0.09919 















wall thickness 0.02 mm) and measurements were performed at 20 C. Data were collected in 10 
successive 1 second frames, to minimize the effects of radiation damage, with pre- and post-
sample buffer measurements for subsequent background subtraction. The 2D data were 
normalized to an absolute scale calibrated using the scattering from water and azimuthally 
averaged to obtain 1D intensity profiles. Profiles with observable radiation damage were 
discarded prior to averaging and buffer subtraction. Scattering data was collected for Fab A33 at 
1.0 mg/ml and 20 C, at all combinations of pH 3.5, 4.5, 5.5, 7.0 and 9.0 and ionic strengths 20, 
50, 150 and 250 mM. Buffers at pH 3.5, 4.5 and 5.5 were 20 mM sodium acetate, at pH 7.0 in 
20 mM sodium phosphate, and at pH 9.0 in 20 mM Tris.HCl buffer. Ionic strength was set via 
the addition of NaCl. 
 
Two types of SAXS analyses were performed to determine the radius of gyration Rg of 
the protein and its molecular weight from the forward scattered intensity I(0). Guinier analyses at 
low Q values up to a Q.Rg of 1.5 were based on linear fits using ln I(Q) vs Q
2 plots:  
ln I(Q) = ln I(0) – Rg
2 Q2/3 
Fourier transformation of the full scattering curve I(Q) in reciprocal space into real space gave 
the distance distribution function P(r) that represented all the distances between the atoms in 
the protein. The maximum in P(r) corresponded to the most commonly occurring distance and 
the cutoff at large r represented the protein length. Guinier fits and P(r) transformations utilized 
the programs SCT and GNOM [29,65]. 
 
Fab A33 homology model using Rosetta 
We generated a homology model of Fab A33 using the Rosetta method “minirosetta” 
and the crystal structure of human germline antibody 5-51/O12 (PDB ID 4KMT) as the template 















disulfide bonds intact. From these, 1000 structures with the lowest Rosetta Energy Units were 
selected, and clustered based on their similarities. The largest category in the clustering step 
contained 573 structures, and the structure with the lowest score in this category was selected 
as the homology model of Fab A33 [68]. 
 
Molecular dynamic simulations  
Molecular dynamic (MD) simulations on the Fab A33 homology model were carried out 
using Gromacs v5.0 [26]. MD simulations of 50 ns were carried at pH 3.5, 4.5, 5.5, 7.0 and 9.0, 
all at an ionic strength of 50 mM, using the OPLS-AA/L all-atom force field [69]. Simulations 
were generated at 300 K, 340 K and 380 K to increase the range of energy to the system and 
generate more variable structures. Three independent simulations were carried out for all 
conditions. The topology file retained the five (four intra and one inter) disulfide bonds of Fab. 
The protonation state of each residue was entered manually, and these were determined at 
each pH using the PDB2PQR server, which performed the pKa calculations by PropKa [25]. The 
Fab A33 structure was placed in a cubic box with a layer of water up to at least 10.0 Å from the 
protein surface. The box was solvated with SPC/E water molecules, Cl- added to neutralize the 
net charges, and NaCl added to 50 mM. The system was energy minimized (relaxed), using the 
steepest descent algorithm (2000 steps) followed by the conjugate gradient method (5000 
steps), then the solvent and ions around the protein were equilibrated for 100 ps under NVT 
ensemble to stabilize at 300 K, and then at 100 ps under NPT ensemble to stabilize at 
atmospheric pressure (position-restricted simulations). MD simulations were carried out on the 
UCL Legion High Performance Computing Facility. The time step of the simulations was set to 2 

















SCT software for SAXS curve calculations  
The theoretical X-ray scattering curve was calculated using SCT software for each of the 
MD models (45,000 models per pH) for comparison with the experimental SAXS data [29]. 
Coarse-grained models were created from the atomistic structures by placing the latter in a 
cubic grid of boxes and replacing boxes with spheres if sufficient atoms were present. We used 
a standard box side of 0.54 nm and cutoff of 4 atoms (confirmed using one of the structures at 
the end of a pH 3.5 simulation), and adding a hydration shell of 0.3 g water per gram protein 
because SAXS visualizes the layer of water in contact with the protein. The theoretical 
scattering curves were calculated using Debye’s Law adapted to spheres.  The experimental 
and theoretical curves were compared using the R-factor, with low R-factors representing the 
better fits, which were computed in the Q range: 0.37-1.6 nm-1.  
 
𝑅 =  




Single-Molecule FRET  
Confocal fluorescence spectroscopy  
Single-molecule fluorescence measurements were carried out on a MicroTime 200 
confocal microscope (PicoQuant, Germany). For excitation, a diode laser at the donor excitation 
wavelength was used (LDH-D-C-485, PicoQuant, Germany), at 20 MHz (laser pulse every 50 
ns) and a laser power of 100 µW at the back aperture of the objective. The laser was focused 
into the sample solution with an UPlanApo 60x/1.20W objective (Olympus). Measurements were 
performed by placing the confocal volume 50 m into the solution relative to the cover slide 
surface. The fluorescence signal was collected by the same objective and filtered with a 















through a 100 µm pinhole. Donor and acceptor photons were separated by a second dichroic 
mirror, 585 DCXR, and further filtered by band-pass filters, ET525/50M for donor, and 
ET645/75M for acceptor (all Chroma Technology). Finally, photons were detected using two 
single-photon avalanche photodiodes (-SPAD) (PicoQuant). The arrival time of every detected 
photon was recorded with a HydraHarp 400 counting module (PicoQuant). 
Single-molecule measurements were acquired at a protein concentration of <100 pM. 
The measurements were performed in 20 mM sodium phosphate buffer pH 7.0 and 20 mM 
sodium citrate buffer pH 3.5, both 50 mM final ionic strength adjusted with NaCl. Despite the low 
pH, the fluorescence quantum yields of the dyes remained the same [70]. Each sample was 
measured for 30 min at room temperature.  
 
Single-Molecule Data Analysis  
First, the raw data was converted to the Photon-HDF5 file format (.h5) using the open 
source software Photon-HDF5 [71]. Next, single-molecule FRET data was analyzed using the 
open source software FRETBursts [72]. We followed the steps for background estimation, burst 
search, burst selection and computation of FRET efficiency histograms. Background rates were 
calculated first, by plotting a histogram of inter-photon delay times in windows of 30 s. Signal 
from single-molecules can be differentiated from background because single molecules show 
short delay times whereas background signal follows a Poisson process that is exponentially 
distributed. By fitting the long delay times to an exponential, the background rates were 
calculated. After background calculation, bursts corresponding to single-molecules traversing 
the excitation volume were identified. We identified a burst if the rate of photons was 6 times 
faster than the local background rate, and we used 10 consecutive photons to compute the local 
count rate. For this calculation, all photons were taken into account (donor and acceptor). After 
burst identification, corrections were applied. Bursts were corrected for background and donor 















excitation and -factor correction were applied, thus the conversions of FRET efficiencies to 
distances were not possible. In this study, we refer to the calculated FRET efficiencies as 
“apparent FRET efficiencies” (Eapp) [32,40,41], which allowed the relative comparison between 
Fab A33 constructs and solution conditions. We applied a size filter to the previous bursts 
found, where only bursts with more than 30 photons were kept. Lastly, apparent transfer 
efficiency histograms were calculated for each burst using the expression Eapp = nA/(nA+nD); 
where nD and nA are the numbers of donor and acceptor photons in the burst, respectively, and 
apparent FRET efficiencies were fitted to Gaussian functions. 
 
Aggregation Prediction Regions Software 
Sequence-based aggregation prone regions (APR) of Fab A33 were predicted using PASTA 2.0 
[47], TANGO [45] AGGRESCAN [46] and MetAmyl [48]. The regions in which three out of the 
four software identified an aggregation-prone region were selected, resulting in seven APRs. 
Amylpred2 consensus tool was used to confirm the presence of these APRs. Additionally, a 
consensus was created between the four sequence-based software, (Normalized TANGO * 1/4 
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Fig 1. Structure of native Fab A33. Fab is composed of light (magenta) and heavy (yellow) 
chains. Each chain contains variable (VL and VH) and constant (CL and CH1) domains. The 
antigen-binding region at the complementary determining regions (CDRs; blue), are located in 
the variable domains. There are five disulphide bonds (gray highlights), four of them being intra-
domain in VL, VH, CL and CH1, and the fifth is at the C-terminus between the light and heavy 
chains. The Fab A33 sequence is reported in Fig. S1. 
 
Fig 2. SAXS Guinier analyses. Twenty experimental conditions were studied for Fab A33 
using five pH (3.5, 4.5, 5.5, 7.0, 9.0) and four ionic strengths (20, 50, 150, 250 mM).  (a) Guinier 
plots of ln I(Q) vs. Q2 gave the Rg and I(0) values. Five representative fits are shown for each of 
pH 3.5, 4.5, 5.5, 7.0 and 9.0 in an ionic strength of 50 mM. The fits for native Fab A33 were 
determined using the Q range of 0.37-0.5 nm -1 (green) and those for aggregated Fab A33 was 
determined from the Q range of 0.14-0.3 nm-1 (red). (b) I(0) values for native Fab A33, where 
I(0)/c is proportional to the molecular weight, and error bars are the SEM of three 
measurements. (c) Rg values for native Fab A33 for each of the 20 experimental conditions 















present was determined from ΔI(0)/c, defined as (I(0)Q: 0.14-0.3 nm 
-1
 – I(0) Q: 0.37-0.5 nm 
-1)/c. 
 
Fig 3. Correlation between the Rg values and aggregation rates v. For each pH (see inset), 
the averaged Rg values for native Fab A33 and the aggregation rates v are shown for the four 
ionic strengths. Error bars are the SEM.   
 
Fig 4. MD simulations of native Fab A33 at 300 K. (a, b) The Rg values and solvent 
accessible surface area (SASA) of Fab A33 are shown as a function of simulation time for five 
pH values as labelled, using an ionic strength of 50 mM for each. For each pH, three simulation 
repeats were averaged at every time frame, from which a window average is shown in a darker 
colour. (c, d) The root mean square fluctuation (RMSF) of the simulations at pH 7.0 and pH 3.5 
respectively are shown in blue (low values) and red (high values) to highlight the dynamic 
regions in the structure. Front and back views are shown to follow the view of Figure 1. The 
RMSF values were added as notional B-factors to the PDB file for the Fab A33 homology 
model.  
 
Fig 5. Comparison of the SAXS data with the MD simulations. (a) Comparison of the 
experimental X-ray scattering curve for native Fab A33 with the structures generated from the 
MD simulations for the five pH values as shown. MD simulations were carried out using an ionic 
strength of 50 mM at three temperatures of 300 K (green), 340 K (purple) and 380 K (grey). In 
total, each experimental SAXS curve was compared against 45,000 simulated structures per pH 
value. The goodness of fit was monitored using R-factors (Methods). The vertical lines 
represent the experimental Rg values with their experimental errors (SEM). The Rg value of 
each model was calculated from the theoretical scattering curve using the same Q-range used 
experimentally. The 10 best fit models with the lowest R-factors are highlighted in yellow. (b) 















(red). The inset shows the comparison between the experimental and best fit modelled P(r) 
curves.  
 
Fig 6. Alignment of the best-fit Fab A33 structures at pH 7.0. The ten best-fit simulated 
structures determined for pH 7.0 and an ionic strength of 50 mM are aligned in a cartoon 
representation. (a) Alignment of the light chain; (b) Alignment of the heavy chain.  
 
Fig 7. Alignment of the best fit Fab A33 structures at pH 7.0 and 3.5. The ten best-fit 
simulated structures determined for pH 7.0 are shown in cyan and those for pH 3.5 are shown in 
magenta; both at an ionic strength of 50 mM. (a) Alignment of the light chain in which the CL 
domain is highlighted to show its loop and helix displacements at low pH in three views. (b) 
Alignment of the heavy chain, in which a side view of the CH1 domain is shown. 
 
Fig 8. Distance monitoring using smFRET, SAXS and MD simulations. Two separations 
termed Dist 1 (residues LC-K126 and LC-S156) and Dist 2 (residues HC-S117 and LC-S156) 
were monitored at pH 7.0 and pH 3.5 in an ionic strength of 50 mM each. (a) Apparent single-
molecule FRET efficiency (Eapp) histograms of Dist 1 (green) and Dist 2 (gray) at pH 7.0 (dark 
colour) and pH 3.5 (light colour). At a FRET efficiency of 0.0, the population of molecules 
without an active acceptor fluorophore is shaded in gray. At higher FRET efficiencies, there is a 
population that corresponds to Fab A33 containing both fluorophores. This population was fitted 
with a Gaussian function and the peak is shown with a vertical line. (b) The averaged Dist 1 and 
2 separations and their SD were measured from the ten best-fit SAXS structures at each of pH 
7.0 (cyan) and pH 3.5 (magenta). (c) The Dist 1 (green) and Dist 2 (gray) separations as a 
function of simulation time for pH 7.0 (dark colour) and 3.5 (light colour) are shown from the MD 
simulations. Three simulation repeats were averaged at every time frame, from which a window 
















Fig 9. Aggregation prone regions in Fab A33. (a) The consensus aggregation propensity of 
residues in Fab A33 was determined using PASTA 2.0, TANGO, AGGRESCAN and MetAmyl 
software. Using the native Fab A33 homology model, regions with greater aggregation 
propensities are shown in red and reduced propensities in blue. (b, c) Aggregation propensities 
in the SAXS best-fit structure for pH 7.0 and 3.5, respectively, are shown using a CPK spheres 
representation. The circled residues highlight the increase in SASA of APR 387-402 at pH 3.5 


















1.     Elucidation of local changes in native conformation that promote protein aggregation. 
2.     Unprecedented resolution of native-like conformers by fitting MD simulations to 
SAXS data. 
3.     smFRET of dual-labelled Fab A33 confirms conformational changes. 
4.     Local unfolding of Fab A33 exposes a predicted aggregation-prone region. 
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